Cerevast has a deep portfolio of clinical and development stage programs to improve patient care across the heath care continuum.

Clinical Stage Programs

  • Transcranial ultrasound plus tissue plasminogen activator for the treatment of ischemic stroke
    (Open IDE, Phase 3)
  • Ophthalmic ultrasound plus microspheres for the treatment of retinal vein occlusions
    (Open IDE, Phase 2)

Development Stage Programs

  • Transcranial ultrasound for neuromodulation and post-stroke recovery
  • Ultrasound plus microspheres for enhanced drug delivery

Refer to the August 2020 IEEE review article for an independent overview of many of therapeutic applications that Cerevast is pursuing.

Pipeline Image